Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Doxycycline that is taken as post-exposure prophylaxis (PEP) is effective in reducing the incidence of chlamydia and gonorrhea in men who have sex with men and transgender women.News Article updated on 04/11/2023
-
Advancing Implementation Science: HRSA Technical Expert Panel Insights
Overview of implementation science activities for the Ryan White HIV/AIDS Program (RWHAP) and feedback on future directions.News Article updated on 04/14/2023 -
Health Disparities
Ensuring health equity within projects.Resource (Conference Presentation) updated 09/14/2023
-
Housing First to Treat and Prevent HIV
Intervention using three interconnected approaches to improve retention in HIV care: housing first, harm reduction, and Motivational Interviewing.Resource updated 10/13/2023
-
Health Centers on the Front Lines Podcast: Status Neutral
Review of concept of status neutral (access to HIV services regardless of HIV status).Resource updated 10/24/2023
-
Micro Learning: Black Cisgender and Trans Women, HIV Treatment, & PrEP
Learn how to improve messaging about HIV prevention and care to improve acceptance of services among all Black women.Resource updated 05/10/2023
-
RWHAP Part B and ADAP Succession Planning Guide
Toolkit to assist health departments, specifically RWHAP Part B and ADAPs, to prepare succession plans for staff as they take on new roles.Resource updated 09/19/2023
-
Navigator Case Management for People Leaving Jail
The Navigator Case Management intervention helps people with HIV who are incarcerated and are leaving to return to the community. The intervention uses harm reduction, case management, and motivational interviewing techniques to promote healthy behaviors. Enhanced case management including peer support and connection to other needed services both immediately before and after release supports increased linkage to and retention in HIV care for people transitioning to the community from jail.Resource from the RWHAP Best Practices Compilation updated on 01/19/2024
-
Use of RWHAP Funds for Health Care Coverage Costs
Overview of RWHAP payment for clients’ health care coverage costs (insurance assistance).Resource updated 09/19/2023
-
Ryan White Conference Database Expands
A searchable database is now available to access slides and videos from HRSA Ryan White Conferences stretching back to 2020.Blog updated 03/28/2024
-
Aging with HIV Initiative
SPNS project evaluating interventions that seek to improve the well-being of RWHAP clients 50 and older. Project period: 2022-2025.RWHAP Technical Assistance Provider updated on 02/27/2024
-
Behavioral Health Models to Improve HIV Health Outcomes for Black Men Who Have Sex With Men
Resources to facilitate the replication or adaption of successful interventions for engaging Black MSM in HIV care.Resource updated 03/04/2024
-
LINK LA
LINK LA is a 12-session, 24-week peer navigation intervention for people with HIV who are scheduled to be released from incarceration. LINK LA peer navigators focus on behavioral changes that promote medication adherence and retention in care, while providing social support and facilitating communication with medical providers. LINK LA showed improvements in linkage to and retention in HIV care and viral suppression among people with HIV re-entering the community after incarceration.Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
-
Telemedicine to Achieve HIV Viral Suppression in Incarcerated People in Tennessee – 9-year retrospective (2010 – 2018)
In collaboration with Tennessee Department of Corrections, we developed and implemented a stepwise HIV telemedicine program to optimize viral suppression in the state prisons during 2010-2018. Clinic attendance increased from 50 percent to 90 percent during full implementation. Viral suppression increased from 30 percent in 2010 to 90 percent in 2018.
Resource (Conference Presentation) updated 09/14/2023
-
Promising Practices: The Impact of COVID-19 Related Policy Changes On Enrollment Capacity Within California's ADAP
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
-
Navigating HIV services for Deaf, Hard of Hearing, and DeafBlind
Barriers to care for deaf people living with HIV and best practices for engaging them in care and providing culturally relevant HIV services.
Resource (Conference Presentation) updated 09/14/2023
-
Corrections and community for continuity of HIV care upon re-entry
Development of a referral processes for persons re-entering the community from incarceration (in SOAR program), with referrals prior to release, resulting in higher rate of first appointments within 30-days; challenges for linkage to care through SOAR remain after release.
Resource (Conference Presentation) updated 09/14/2023
-
National ADAP Formulary Database
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
-
ADAP Emergency and Service Disruption Preparedness Resource Guide
Guide to help ADAPs prepare for and manage emergencies in order to ensure continued access to HIV medications.
Resource updated 09/19/2023
-
340B Drug Pricing Program
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023